About Ventrix
Ventrix is a company based in San Diego (United States) founded in 2009 by Karen Christman and Adam Kinsey. It operates as a HealthTech. The company has 2 employees. Ventrix offers products and services including ECM Biotherapeutics. Ventrix operates in a competitive market with competitors including Kerecis, Tenaya Therapeutics, Cellino, MyoKardia and Eiger BioPharmaceuticals, among others.
- Headquarter San Diego, United States
- Employees 2
- Founders Karen Christman, Adam Kinsey
- SectorsHealthcare
- Website ventrixbio.com
- Social LinkedIn
- Legal Name Ventrix Bio
- Latest Funding Round$1.99M (USD), Grant
Sep 2023
- Investors
- Employee Count2
Products & Services of Ventrix
Ventrix offers a comprehensive portfolio of products and services, including ECM Biotherapeutics.
Biotherapeutics using ECM to support tissue repair processes.
Funding Insights of Ventrix
- Total Rounds 6
- Last Round Grant — $1.99M
- First Round $180,000
(Jul 2010)
- Investors Count 1
All 6 funding rounds of Ventrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
1 investors in total: 1 institutional.
Investors in Ventrix
Ventrix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Ventrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Ventrix
2 people are tracked at Ventrix (2 in leadership); the tracked headcount is 2.
| Name | Role | Group |
|---|---|---|
Karen Christman | Co-Founder | Leadership |
Adam Kinsey | Co-Founder & CEO | Leadership |
Complete people profiles for Ventrix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Ventrix
3 dated milestones of Ventrix across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Ventrix is founded.
- Funding First funding round of $180K.
- Funding Latest funding round, Grant, of $2.0M.
Competitors of Ventrix
Ventrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kerecis, Tenaya Therapeutics, Cellino, MyoKardia and Eiger BioPharmaceuticals, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kerecis.com | 2007 | Isafjordur, Iceland | $93.11M | 150 | Fish-skin acellular dermal matrix technology is provided for wound treatments. | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies | |
| myokardia.com | 2012 | San Francisco, United States | $98M | 224 | Specialized drugs are developed for genetic heart diseases. | |
| eigerbio.com | 2000 | San Carlos, United States | $8.9M | 56 | Developer of antiviral agents against targets in the treatment of hepatitis | |
| arrakistx.com | 2015 | Waltham, United States | $113M | 91 | Provider of tools for the analysis of RNA structures | |
| cardurion.com | 2017 | Boston, United States | $270M | – | Therapeutics for heart and cardiovascular diseases are developed. | |
| capricor.com | 2005 | Los Angeles, United States | – | 62 | Regenerative medicine for cardiovascular disorders is developed using cell-based platforms. | |
| esperion.com | 1998 | Ann Arbor, United States | $129.7M | 240 | Therapies for lowering low-density lipoprotein cholesterol levels are developed. |
Detailed competitors of Ventrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Ventrix
The website of Ventrix (ventrixbio.com) receives about 1.8K visits a month.
- Monthly visits1.8K
▲ 62.6% vs previous month
Websites whose visitors overlap most with Ventrix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gribio.com | 100% | 3.1K | #5,745,404 | View details | |
| novoron.com | 99% | 1.4K | #11,323,898 | View details | |
| abdesignlabs.com | 98% | 4.7K | #4,128,811 | View details | |
| nanome.ai | 98% | 3.9K | #4,650,815 | View details | |
| curemetrix.com | 94% | 2.7K | #5,895,624 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Ventrix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Ventrix
Complete news archive for Ventrix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Ventrix
10 companies that operate in the same segment as Ventrix (Organ-on-Chip & Regenerative Solutions), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Human tissue-based products are developed for vascular disease applications. | 2004 | Morrisville, United States | USD 424.76 M | USD 2.04 M | 220 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Products for regenerative and respiratory medicine are developed and distributed. | 1992 | Cambridge, Cambridgeshire, United Kingdom | – | USD 71.61 M | 260 | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Personalized skin tissue therapy is developed by CUTISS for surgeries. | 2017 | Zurich, Switzerland | USD 94.37 M | – | – | |
Synthetic adhesives for bone and dental repair are developed. | 2014 | Lowell, Massachusetts, United States | USD 24.42 M | – | – | |
Injectable synthetic bone substitutes are developed for fracture treatment. | 2000 | Lund, Sweden | USD 101.08 M | USD 127.04 M | 139 | |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool | 2019 | Boston, Massachusetts, United States | USD 205 M | – | 52 | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Reconstructive and regenerative solutions for bone conditions are developed. | 1980 | Lewisville, Texas, United States | – | USD 822.31 M | 1,620 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ventrix
Ventrix was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Ventrix is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Adam Kinsey is the current CEO of Ventrix. They have also founded this company.
Ventrix has 2 employees.
Ventrix Bio is engaged in developing biotherapeutics using extracellular matrix (ECM) to facilitate tissue repair. The company operates in the biotechnology sector, focusing on solutions that replicate the natural scaffolding of cells to guide the body in generating healthy microenvironments and tissues. Their approach addresses the critical role of ECM in cell behavior and tissue function across various medical applications.
Ventrix's top competitors include Esperion Therapeutics, Tenaya Therapeutics and Kerecis.
Ventrix offers ECM Biotherapeutics.
Ventrix has 1 investor. Key investors include HHS.
Ventrix operates through Ventrix Bio.